Advertisement
Screener

LEXICON PHARMACEUTICALS, INC. (LXRX) Shares Outstanding (Cover Page)

2.1 / 5 stars · 33/79 Roast Me

LEXICON PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)

LEXICON PHARMACEUTICALS, INC. (LXRX) had Shares Outstanding (Cover Page) of 444.96 million shares as of 2026-08-03, per its 10-Q filed 2026-08-06.

Financial Statements › Notes › Cover Page

dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06

  • 2026-08-03: Entity Common Stock, Shares Outstanding 444.96M shares.
  • 2026-05-04: Entity Common Stock, Shares Outstanding 444.20M shares.
  • 2026-03-04: Entity Common Stock, Shares Outstanding 423.68M shares.
  • 2025-11-04: Entity Common Stock, Shares Outstanding 363.40M shares.
Period endEntity Common Stock, Shares OutstandingEntity Common Stock, Shares Outstanding as first filed
2026-08-03444.96M shares
10-Q · filed 2026-08-06
2026-05-04444.20M shares
10-Q · filed 2026-05-07
2026-03-04423.68M shares
10-K · filed 2026-03-05
2025-11-04363.40M shares
10-Q · filed 2025-11-06
2025-08-01363.40M shares
10-Q · filed 2025-08-06
2025-05-09363.18M shares
10-Q · filed 2025-05-14
2025-02-28361.49M shares
10-K · filed 2025-03-07
2024-11-08361.49M shares
10-Q · filed 2024-11-13
2024-07-30361.49M shares
10-Q · filed 2024-08-02
2024-04-29246.24M shares
10-Q · filed 2024-05-02
2024-03-21246.24M shares
10-K · filed 2024-03-25
2023-11-06244.92M shares
10-Q · filed 2023-11-08
2023-08-01244.92M shares
10-Q · filed 2023-08-04
2023-03-01188.73M shares
10-K · filed 2023-03-03
2022-11-07189.56M shares
10-Q · filed 2023-05-04
188.73M shares
10-Q · filed 2022-11-09
2022-08-03183.63M shares
10-Q · filed 2022-08-03
2022-05-04149.59M shares
10-Q · filed 2022-05-05
2021-11-01148.90M shares
10-Q · filed 2021-11-09
2021-08-03144.47M shares
10-Q · filed 2021-08-06
2021-05-04144.39M shares
10-Q · filed 2021-05-06
2020-10-26117.47M shares
10-Q · filed 2020-10-30
2020-07-24107.11M shares
10-Q · filed 2020-07-29
2020-04-23106.97M shares
10-Q · filed 2020-04-27
2020-03-06144.35M shares
10-K · filed 2021-03-12
106.97M shares
10-K · filed 2020-03-12
2019-11-04106.27M shares
10-Q · filed 2019-11-07
2019-07-29106.27M shares
10-Q · filed 2019-08-01
2019-04-29106.27M shares
10-Q · filed 2019-05-01
2019-03-08106.27M shares
10-K · filed 2019-03-15
2018-10-29105.93M shares
10-Q · filed 2018-11-01
2018-07-26105.88M shares
10-Q · filed 2018-07-30
2018-04-30105.83M shares
10-Q · filed 2018-05-03
2018-02-26105.59M shares
10-K · filed 2018-03-01
2017-11-06105.59M shares
10-Q · filed 2017-11-08
2017-07-28105.58M shares
10-Q · filed 2017-08-01
2017-05-01105.24M shares
10-Q · filed 2017-05-04
2017-03-01104.32M shares
10-K · filed 2017-03-06
2016-11-03104.04M shares
10-Q · filed 2016-11-07
2016-08-01103.87M shares
10-Q · filed 2016-08-04
2016-05-02103.82M shares
10-Q · filed 2016-05-05
2016-03-07103.77M shares
10-K · filed 2016-03-11
2015-11-04103.62M shares
10-Q · filed 2015-11-09
2015-08-04103.61M shares
10-Q · filed 2015-08-07
2015-05-01725.29M shares
10-Q · filed 2015-05-05
2015-03-09725.15M shares
10-K · filed 2015-03-12
2014-11-04514.83M shares
10-Q · filed 2014-11-06
2014-08-04514.82M shares
10-Q · filed 2014-08-07
2014-05-06514.94M shares
10-Q · filed 2014-05-08
2014-02-27513.79M shares
10-K · filed 2014-03-07
2013-11-08513.52M shares
10-Q · filed 2013-11-12
2013-07-29513.45M shares
10-Q · filed 2013-08-01
2013-05-06513.03M shares
10-Q · filed 2013-05-10
2013-03-08513.00M shares
10-K · filed 2013-03-11
2012-11-05512.37M shares
10-Q · filed 2012-11-07
2012-07-31494.34M shares
10-Q · filed 2012-08-02
2012-05-01480.66M shares
10-Q · filed 2012-05-03
2012-03-05480.56M shares
10-K · filed 2012-03-08
2011-10-28337.68M shares
10-Q · filed 2011-11-01
2011-08-04337.68M shares
10-Q · filed 2011-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
GERON CORP (GERN)United States$0.803B-12.14
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78